Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Immunization with DNA vaccines containing porcine reproductive and respiratory syndrome virus open reading frames 5, 6, and 7 may be related to the exacerbation of clinical disease after an experimental challenge.

Díaz I, Ganges L, Galindo-Cardiel I, Tarradas J, Alvarez B, Lorca-Oró C, Pujols J, Gimeno M, Darwich L, Domingo M, Domínguez J, Mateu E.

Viral Immunol. 2013 Feb;26(1):93-101. doi: 10.1089/vim.2012.0041.

PMID:
23409932
2.

Immune responses of swine following DNA immunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFNgamma.

Xue Q, Zhao YG, Zhou YJ, Qiu HJ, Wang YF, Wu DL, Tian ZJ, Tong GZ.

Vet Immunol Immunopathol. 2004 Dec 8;102(3):291-8.

PMID:
15507312
3.

Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.

Pujhari S, Baig TT, Hansra S, Zakhartchouk AN.

Virus Res. 2013 May;173(2):321-6. doi: 10.1016/j.virusres.2013.01.011. Epub 2013 Jan 23.

PMID:
23353778
4.

Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.

Martelli P, Gozio S, Ferrari L, Rosina S, De Angelis E, Quintavalla C, Bottarelli E, Borghetti P.

Vaccine. 2009 Jun 8;27(28):3788-99. doi: 10.1016/j.vaccine.2009.03.028. Epub 2009 Apr 3.

PMID:
19442420
5.

Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.

Ren J, Lu H, Wen S, Sun W, Yan F, Chen X, Jing J, Liu H, Liu C, Xue F, Xiao P, Xin S, Jin N.

J Virol Methods. 2014 Sep;206:27-37. doi: 10.1016/j.jviromet.2014.05.021. Epub 2014 May 29.

PMID:
24882496
6.

DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity.

Jiang Y, Xiao S, Fang L, Yu X, Song Y, Niu C, Chen H.

Vaccine. 2006 Apr 5;24(15):2869-79. Epub 2006 Jan 18.

PMID:
16446016
7.
8.

Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.

Charerntantanakul W, Platt R, Johnson W, Roof M, Vaughn E, Roth JA.

Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):99-115. Epub 2005 Sep 13.

PMID:
16165219
9.

Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.

Du Y, Qi J, Lu Y, Wu J, Yoo D, Liu X, Zhang X, Li J, Sun W, Cong X, Shi J, Wang J.

Virus Genes. 2012 Dec;45(3):474-87. doi: 10.1007/s11262-012-0790-1. Epub 2012 Jul 28.

PMID:
22843314
10.

Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.

Rompato G, Ling E, Chen Z, Van Kruiningen H, Garmendia AE.

Vet Immunol Immunopathol. 2006 Jan 15;109(1-2):151-60. Epub 2005 Sep 12.

PMID:
16162362
11.

Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.

Park C, Oh Y, Seo HW, Han K, Chae C.

Clin Vaccine Immunol. 2013 Mar;20(3):369-76. doi: 10.1128/CVI.00497-12. Epub 2013 Jan 9.

12.

Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.

Kim T, Park C, Choi K, Jeong J, Kang I, Park SJ, Chae C.

Clin Vaccine Immunol. 2015 Jun;22(6):631-40. doi: 10.1128/CVI.00001-15. Epub 2015 Apr 8.

13.

Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.

Shen G, Jin N, Ma M, Jin K, Zheng M, Zhuang T, Lu H, Zhu G, Jin H, Jin M, Huo X, Qin X, Yin R, Li C, Li H, Li Y, Han Z, Chen Y, Jin M.

Vaccine. 2007 May 22;25(21):4193-202. Epub 2007 Mar 22.

PMID:
17418456
14.

Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in protection.

Plana Duran J, Climent I, Sarraseca J, Urniza A, Cortés E, Vela C, Casal JI.

Virus Genes. 1997;14(1):19-29.

PMID:
9208452
15.

Age-dependent resistance to Porcine reproductive and respiratory syndrome virus replication in swine.

Klinge KL, Vaughn EM, Roof MB, Bautista EM, Murtaugh MP.

Virol J. 2009 Oct 27;6:177. doi: 10.1186/1743-422X-6-177.

16.

Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.

Ferrari L, Martelli P, Saleri R, De Angelis E, Cavalli V, Bresaola M, Benetti M, Borghetti P.

Vet Immunol Immunopathol. 2013 Feb 15;151(3-4):193-206. doi: 10.1016/j.vetimm.2012.11.006. Epub 2012 Nov 19.

PMID:
23228653
17.

DNA vaccination of pigs with open reading frame 1-7 of PRRS virus.

Barfoed AM, Blixenkrone-Møller M, Jensen MH, Bøtner A, Kamstrup S.

Vaccine. 2004 Sep 9;22(27-28):3628-41.

PMID:
15315842
18.

The immunogenicity of DNA constructs co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus conjugated by GPGP linker in pigs.

Chia MY, Hsiao SH, Chan HT, Do YY, Huang PL, Chang HW, Tsai YC, Lin CM, Pang VF, Jeng CR.

Vet Microbiol. 2010 Dec 15;146(3-4):189-99. doi: 10.1016/j.vetmic.2010.05.007. Epub 2010 May 10.

PMID:
20570063
19.

Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.

Park C, Choi K, Jeong J, Chae C.

Vet Microbiol. 2015 May 15;177(1-2):87-94. doi: 10.1016/j.vetmic.2015.02.020. Epub 2015 Feb 26.

PMID:
25769646
20.

Supplemental Content

Support Center